IL15 and neoplasm: These strategies include use of small molecules or genetic modification to ensure auto/paracrine cytokine (IL-15) support in vivo, enhance NK cell infiltration and function in the tumor micro-environment, block inhibitory receptors, augment antigen recognition, and enhance activating signals.